Hemostemix's market cap is currently C$28.21M. The company's EPS TTM is C$-0.023; its P/E ratio is ―; Hemostemix is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -223.00	C$ -495.00	C$ -1.10K	C$ -2.45K	C$ -1.69K
Operating Income	C$ -2.33M	C$ -4.58M	C$ -6.67M	C$ -7.47M	C$ -4.70M
EBITDA	C$ -1.95M	C$ -4.39M	C$ -6.45M	C$ -7.47M	C$ -4.76M
Net Income	C$ -2.50M	C$ -5.24M	C$ -6.29M	C$ -7.77M	C$ -4.87M
Balance Sheet
Cash & Short-Term Investments	C$ 155.42K	C$ 135.75K	C$ 219.44K	C$ 257.95K	C$ 24.06K
Total Assets	C$ 313.76K	C$ 465.35K	C$ 563.05K	C$ 2.32M	C$ 104.28K
Total Debt	C$ 4.32M	C$ 4.13M	C$ 1.48M	C$ 175.00K	C$ 2.06M
Net Debt	C$ 4.17M	C$ 3.99M	C$ 1.26M	C$ -82.95K	C$ 2.04M
Total Liabilities	C$ 7.68M	C$ 7.23M	C$ 5.85M	C$ 3.42M	C$ 4.15M
Stockholders' Equity	C$ -7.37M	C$ -6.77M	C$ -5.28M	C$ -1.10M	C$ -4.05M
Cash Flow
Free Cash Flow	C$ -1.42M	C$ -6.10M	C$ -3.48M	C$ -5.98M	C$ -3.41M
Operating Cash Flow	C$ -1.42M	C$ -6.10M	C$ -3.48M	C$ -5.98M	C$ -3.40M
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 171.12K	C$ 0.00	C$ -6.14K
Financing Cash Flow	C$ 1.44M	C$ 6.02M	C$ 3.27M	C$ 6.21M	C$ 1.96M

Currency in CAD

Hemostemix Earnings and Revenue History

Income Statement >

Hemostemix Debt to Assets

Balance Sheet >

Hemostemix Cash Flow

Cash Flow >

Hemostemix Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing